 |
Sotalol HCl |
|---|---|
| Trade Name | Betapace |
| Orphan Indication | 1. life-threatening ventricular tachyarrhythmias 2. Prevention of life treatening ventricular tachyarrhythmias |
| USA Market Approval | USA |
| USA Designation Date | 1988-09-23 00:00:00 |
| Sponsor | Berlex Laboratories, Inc.;300 Fairfield Road;Wayne, New Jersey, 07470 |
